Using 18F‐MK6240 as a tau PET tracer may have provided a more optimal identification of early‐stage AD but the findings were not able to distinguish between A+T− and A+TMTL+ based on plasma p‐tau217. The gene discussed is MAPT; the disease is Alzheimer disease.